The Best (and Worst) Cannabis Stocks on the TSX in 2020

Many pundits forecast a bounce-back of cannabis stocks this year. However, this trend won’t be equally experienced by all cannabis companies. Companies like Aphria are set to soar, while others, like CannTrust, are expected to tank.

edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

2019 wasn’t great for cannabis stocks, as companies in the sector saw share values plunge sharply over the course of that year. However, many pundits forecast a bounce-back of cannabis stocks this year.

Yet, this trend won’t be equally experienced by all cannabis companies. Here are the best (and worst) cannabis stocks to invest in this year.

Best stock

Aphria (TSX:APHA)(NYSE:APHA), with a market cap of $1.44 billion, is one of the largest cannabis companies in the world. Unlike other businesses in the sector, the company managed to ride the storm that was 2019 fairly well, losing around 20.4% of its value by the year’s end compared to what it was at the start.

For comparison, OrganiGram and Canopy Growth — two other major players in the sector — saw their stocks depreciate by nearly 48.75% and 32%, respectively.

However, analysts predict 2020 to likely be a particularly good year for Aphria. For the last three quarters, Aphria was one of the few cannabis companies to report a positive adjusted ETIBTA. As a result of a rapid increase in sales, and the company pursuing a highly aggressive international expansion policy, the company’s revenue had skyrocketed in the past few years.

In the second quarter of 2019, the figure was just US$43.1 million. By Q2 2020, it has risen to an incredible US$335.3 million. Gross profit has also grown significantly over the same period, doubling from US$35 million to US$80.4 million.

Currently, the company has put its focus on building its presence in Germany, a cannabis market that is far larger than that of Canada. Successful entry into the country could see the company’s sales and profits rise exponentially. The company has also acquired vast tracts land in Columbia for weed cultivation, where the highly favourable climate and soil could significantly reduce the cost of cannabis production.

With a healthy financial outlook and plenty of opportunity for growth and expansion, if cannabis stocks are set to rebound, Aphria’s could soar.

Worst stock

CannTrust Holdings (TSX:TRST)(NYSE:CTST) is one cannabis company you should avoid investing in at all costs. The company could potentially be de-listed from the TSX this year after being involved in a scandal; it was found that, in an attempt to keep prices down, CannTrust was growing black market weed in secret rooms within its facilities.

As a result, the company has been brought under the scrutiny of various regulatory bodies, and it has been given a deadline of March 25, 2020, to file its audited financial restatements for 2018. Should it fail to do so, it will be taken off the Toronto Stock Exchange.

In the past 12 months, its stock has seen a decline in value of 86%, but it could be worth nothing at all should it get de-listed.

Summary

The market for cannabis is quite volatile. If you are seeking an investment with promising returns, Aphria is the way to go. Meanwhile, if you have shares in CannTrust, you’d better reinvest the money elsewhere before its stock completely tanks.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Jason Hoang has no position in any of the stocks mentioned. The Motley Fool recommends CannTrust Holdings and CannTrust Holdings Inc.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »

A cannabis plant grows.
Cannabis Stocks

Can Aurora Cannabis Stock Recover in 2024?

Aurora Cannabis stock is down 99% from all-time highs but remains a high-risk bet, despite its cheap valuation.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

The Best Cannabis Stock to Buy Right Now

This cannabis stock has jumped 30% in the last few months, with even more growth on the way – all…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Down 99% From All-Time Highs, Is Canopy Growth Stock a Good Buy Right Now?

Canopy Growth stock is a high-risk investment due to its negative profit margins and challenging liquidity position.

Read more »

Marijuana plant and cannabis oil bottles isolated
Stocks for Beginners

Aurora Cannabis’ Reverse Stock Split: Is the Stock a Buy Today?

Cannabis stock Aurora (TSX:ACB) is consolidating shares once again, but what does this mean for investors?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Where Will Cannabis Stocks Be in 10 Years?

Cannabis stocks could see a huge shift upwards should marijuana be rescheduled in the U.S., but you can still buy…

Read more »